Literature DB >> 17531612

Worldwide use of intrauterine devices for contraception.

Catherine d'Arcangues1.   

Abstract

The intrauterine device is the most widely used reversible method of contraception in the world today, particularly in developing countries where it is used by 14.5% of women of reproductive age. In the developed world, this percentage is only 7.6%. There are marked regional differences with the highest use in Eastern Asia and the lowest in North America. Such differences between regions and countries can be explained by a number of factors at the individual, service delivery, program and policy levels. The situation in seven countries is briefly described to illustrate this and to conclude that this method of contraception is largely underutilized in many parts of the world, where it could play a significant role in improving women's health.

Entities:  

Mesh:

Year:  2007        PMID: 17531612     DOI: 10.1016/j.contraception.2006.12.024

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  24 in total

1.  Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries.

Authors:  Mieke C W Eeckhaut; Megan M Sweeney; Jessica D Gipson
Journal:  Perspect Sex Reprod Health       Date:  2014-07-14

2.  Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients.

Authors:  Jennifer B Hillman; Rachel J Miller; Thomas H Inge
Journal:  J Womens Health (Larchmt)       Date:  2011-03-17       Impact factor: 2.681

Review 3.  Contraception for cancer survivors.

Authors:  Eleanor Bimla Schwarz; Rachel Hess; James Trussell
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

4.  Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device.

Authors:  Bliss Kaneshiro; Tod Aeby
Journal:  Int J Womens Health       Date:  2010-08-09

5.  Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics.

Authors:  Karrera Y Djoko; Maira M Goytia; Paul S Donnelly; Mark A Schembri; William M Shafer; Alastair G McEwan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

6.  An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device.

Authors:  Reuben M Valenzuela; Ruju Rai; Brian H Kirk; Jessica N Sanders; Subhashree Sundar; Steffen Hamann; Judith E A Warner; Kathleen B Digre; Alison V Crum; Kirtly P Jones; Bradley J Katz
Journal:  Neuroophthalmology       Date:  2017-04-19

7.  Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing.

Authors:  Eleanor Bimla Schwarz; Megan Kavanaugh; Erika Douglas; Tamara Dubowitz; Mitchell D Creinin
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

8.  Dynamics of IUD use in Vietnam: implications for family planning services at primary health care level.

Authors:  Min Hae Park; Thang Huu Nguyen; Thoai Dinh Ngo
Journal:  Int J Womens Health       Date:  2011-12-15

9.  Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa.

Authors:  Felix G Mhlanga; Jennifer E Balkus; Devika Singh; Catherine Chappell; Betty Kamira; Ishana Harkoo; Daniel Szydlo; Shorai Mukaka; Jeanna Piper; Sharon L Hillier
Journal:  Int Perspect Sex Reprod Health       Date:  2019-12-17

10.  The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.

Authors:  Megan N Beatty; Paul D Blumenthal
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.